SCHEMBL15525518

SCHEMBL15525518

CCOC(=O)CSc1nc(-c2cccs2)cc(-c2ccccc2)c1C#N

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.77
▸ ALDH1A1 P00352 7/20 0.70
▸ NPSR1 Q6W5P4 7/20 0.70
▸ HPGD P15428 5/20 0.70
▸ THRB P10828 1/20 0.69
▸ TDP1 Q9NUW8 1/20 0.69
▸ KAT8 Q9H7Z6 1/20 0.68
▸ MEN1 O00255 7/20 0.67
▸ KDM4E B2RXH2 4/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ LMNA P02545 2/20 0.67
▸ PABPC1 P11940 1/20 0.66
▸ PPP1CA P62136 1/20 0.66
▸ EIF4H Q15056 1/20 0.66
▸ SAE1 Q9UBE0 1/20 0.66
▸ UBA2 Q9UBT2 1/20 0.66
▸ POLB P06746 1/20 0.66
▸ MAPT P10636 4/20 0.65
▸ RXFP1 Q9HBX9 3/20 0.65
▸ TSHR P16473 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15525565 0.84 KMT2A (0.75) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL12285554 0.80 KAT8 (0.81) KMT2AALDH1A1NPSR1HPGDTDP1
SCHEMBL19983386 0.80 KMT2A (0.75) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL14596765 0.80 KMT2A (1.00) KMT2AALDH1A1NPSR1HPGDTDP1
SCHEMBL18153581 0.80 KMT2A (0.74) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL12285827 0.79 ALDH1A1 (0.71) KMT2AALDH1A1NPSR1HPGDTHRB
SCHEMBL16686084 0.79 KMT2A (0.64) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL16686161 0.78 KMT2A (0.63) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL16685844 0.77 KMT2A (0.62) KMT2AALDH1A1NPSR1HPGDKAT8
SCHEMBL15525610 0.77 KMT2A (0.64) KMT2AALDH1A1NPSR1HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY UNIV CASE WESTERN RESERVE (US) 2024-02-08 — — US disclosed
US-20210032265-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-02-04 — — US disclosed
US-20210032265-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-02-04 — — US disclosed
US-20200140453-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-05-07 — — US disclosed
US-20200140453-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-05-07 — — US disclosed
US-10301320-B2 Compositions and methods of modulating 15-PGDH activity UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2019-05-28 — — US disclosed
US-10301320-B2 Compositions and methods of modulating 15-PGDH activity UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2019-05-28 — — US disclosed
EP-3295940-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY Case Western Reserve University (US) 2018-03-21 — — EP disclosed
EP-3295940-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY Case Western Reserve University (US) 2018-03-21 — — EP disclosed
US-9790233-B2 Compositions and methods of modulating 15-PGDH activity CASE WESTERN RESERVE UNIVERSITY (US) 2017-10-17 — — US disclosed
EP-2838533-B1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY UNIV CASE WESTERN RESERVE (US) 2017-10-04 — — EP disclosed
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-06-15 — — US disclosed
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-06-15 — — US disclosed
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-06-15 — — US disclosed
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-03-12 — — US disclosed
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-03-12 — — US disclosed
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-03-12 — — US disclosed
EP-2838533-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY Case Western Reserve University (US) 2015-02-25 — — EP disclosed
WO-2013158649-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2013-10-24 — — WO disclosed
WO-2013158649-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2013-10-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885
US-20200140453-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885
US-20240043443-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885
US-20210032265-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885
US-10301320-B2 Compositions and methods of modulating 15-PGDH activity PTGS1, HPGD, PTGIS KMT2A 4177/4885ALDH1A1 415/4885NPSR1 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback